Aminocaproic Acid Tablet
NDC Package 60687-739-25
Package Information
Aminocaproic Acid tablets is a medication used to help control bleeding due to a condition where your blood does not clot the way it normally should (fibrinolysis). This formulation utilizes a tablet delivery system. Marketed by American Health Packaging, this product is identified by NDC 60687-739 and is authorized under FDA application ANDA209060.
Identification & Billing
- RxCUI: 197351 - aminocaproic acid 500 MG Oral Tablet
- RxCUI: 197351 - 6-aminocaproic acid 500 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60687 - American Health Packaging
- 60687-739 - Aminocaproic Acid
- 60687-739-25 - 30 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK (60687-739-95)
- 60687-739 - Aminocaproic Acid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60687-739-25 identifies a specific commercial package of 30 blister pack in 1 carton / 1 tablet in 1 blister pack (60687-739-95) of Aminocaproic Acid, a human prescription drug labeled by American Health Packaging. This tablet is formulated for oral use and contains aminocaproic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Health Packaging on March 10, 2023. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to help control bleeding due to a condition where your blood does not clot the way it normally should (fibrinolysis). This may cause serious bleeding after certain surgeries or in certain conditions (such as bleeding disorders, liver disease, cancer). Aminocaproic acid works by helping your blood clot normally. It belongs to a class of drugs known as antifibrinolytics.
How is this American Health Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60687073925. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.